Study: Pfizer’s Paxlovid reduces Covid risk in seniors regardless of vaccine status | Malay Mail - Malay Mail

JERUSALEM, June 3 — Pfizer Inc’s PFE.N antiviral treatment Paxlovid reduces Covid-19 hospitalisation and death rates in vaccinated and unvaccinated patients 65 years and older,...

JERUSALEM, June 3 Pfizer Incs PFE.N antiviral treatment Paxlovid reduces Covid-19 hospitalisation and death rates in vaccinated and unvaccinated patients 65 years and older, according to a new study … [+2324 chars]

full article...